C9U-33471-03820
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 891 / NV
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-05-03
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Cough, Oropharyngeal pain, Throat irritation — Feeling: GoodFree text: Slight sore throat, then scratchy throat with irritated cough. No fever.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-23
-
2022-01-26
Dose 3 — Pfizer-BioNTech
- 2022-02-01
- 2022-02-02
-
2022-02-09
Survey response — day 14, dose 3MedDRA: Nasopharyngitis — Feeling: FairFree text: Head coldMedDRA releases: 2024-11 · check-in free text available
- 2022-02-16
- 2022-02-23
- 2022-03-02
- 2022-03-09
-
2022-04-27
Survey response — 3 months, dose 3MedDRA: Influenza, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Influenza A and a sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-04-29
- 2022-07-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2022-01-26 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: Slight sore throat, then scratchy throat with irritated cough. No fever.
Release 11 — day 14, dose 3
Symptoms: Head cold
Release 11 — 3 months, dose 3
Symptoms: Influenza A and a sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Throat irritation | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release